OBJECTIVES: We sought to examine the prognostic value of subclinical left ventricular (LV) regional myocardial dysfunction (RMD) measured by magnetic resonance imaging (MRI) among asymptomatic individuals. BACKGROUND: LV RMD, defined as segmental impairment in systolic wall thickening, predicts adverse events in patients with established cardiovascular disease. MRI is highly accurate for detecting subtle RMD, of which the prognostic significance in a large multiethnic asymptomatic population is not known. METHODS: We used MRI to evaluate baseline regional LV myocardial function and prospectively followed a multiethnic (African American, Caucasian, Chinese, and Hispanic) population-based sample of 4,510 men and women without cardiovascular disease for a mean of 4.6 years. Regional myocardial dysfunction was defined as the presence of impaired systolic wall thickening (<10th percentile of segment-specific population distribution) in ≥2 contiguous LV segments within any given coronary artery territory. RESULTS: Baseline prevalence of RMD was 25.6%. Heart failure developed in 34 (1.0%) and 30 (2.6%) participants without and with RMD, respectively (p < 0.001). After adjustment for demographics and traditional risk factors, RMD remained independently associated with incident heart failure (hazard ratio [HR]: 2.62; 95% confidence interval [CI]: 1.56 to 4.39; p < 0.001). The relationship persisted after further adjustment for biomarkers of reported association with cardiovascular disease and indexes of global LV systolic dysfunction and hypertrophy (HR: 1.80; 95% CI: 1.02 to 3.20; p = 0.044). Similarly, RMD independently conferred an increased risk for hard coronary events (myocardial infarction or death from coronary heart disease; HR: 1.75; 95% CI: 1.06 to 2.89; p = 0.029), the composite of hard coronary events and stroke (HR: 1.72; 95% CI: 1.16 to 2.56; p = 0.005), and all atherosclerotic cardiovascular events (HR: 1.50; 95% CI: 1.09 to 2.07; p = 0.012). CONCLUSIONS: Among an asymptomatic multiethnic American cohort, RMD is an independent predictor beyond traditional risk factors and global LV assessment for incident heart failure and atherosclerotic cardiovascular events. The clinical utility of early recognition of this subclinical phenotype deserves further investigation. (Multi-Ethnic Study of Atherosclerosis [MESA]; NCT00005487).
OBJECTIVES: We sought to examine the prognostic value of subclinical left ventricular (LV) regional myocardial dysfunction (RMD) measured by magnetic resonance imaging (MRI) among asymptomatic individuals. BACKGROUND: LV RMD, defined as segmental impairment in systolic wall thickening, predicts adverse events in patients with established cardiovascular disease. MRI is highly accurate for detecting subtle RMD, of which the prognostic significance in a large multiethnic asymptomatic population is not known. METHODS: We used MRI to evaluate baseline regional LV myocardial function and prospectively followed a multiethnic (African American, Caucasian, Chinese, and Hispanic) population-based sample of 4,510 men and women without cardiovascular disease for a mean of 4.6 years. Regional myocardial dysfunction was defined as the presence of impaired systolic wall thickening (<10th percentile of segment-specific population distribution) in ≥2 contiguous LV segments within any given coronary artery territory. RESULTS: Baseline prevalence of RMD was 25.6%. Heart failure developed in 34 (1.0%) and 30 (2.6%) participants without and with RMD, respectively (p < 0.001). After adjustment for demographics and traditional risk factors, RMD remained independently associated with incident heart failure (hazard ratio [HR]: 2.62; 95% confidence interval [CI]: 1.56 to 4.39; p < 0.001). The relationship persisted after further adjustment for biomarkers of reported association with cardiovascular disease and indexes of global LV systolic dysfunction and hypertrophy (HR: 1.80; 95% CI: 1.02 to 3.20; p = 0.044). Similarly, RMD independently conferred an increased risk for hard coronary events (myocardial infarction or death from coronary heart disease; HR: 1.75; 95% CI: 1.06 to 2.89; p = 0.029), the composite of hard coronary events and stroke (HR: 1.72; 95% CI: 1.16 to 2.56; p = 0.005), and all atherosclerotic cardiovascular events (HR: 1.50; 95% CI: 1.09 to 2.07; p = 0.012). CONCLUSIONS: Among an asymptomatic multiethnic American cohort, RMD is an independent predictor beyond traditional risk factors and global LV assessment for incident heart failure and atherosclerotic cardiovascular events. The clinical utility of early recognition of this subclinical phenotype deserves further investigation. (Multi-Ethnic Study of Atherosclerosis [MESA]; NCT00005487).
Authors: Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: B E Ainsworth; W L Haskell; M C Whitt; M L Irwin; A M Swartz; S J Strath; W L O'Brien; D R Bassett; K H Schmitz; P O Emplaincourt; D R Jacobs; A S Leon Journal: Med Sci Sports Exerc Date: 2000-09 Impact factor: 5.411
Authors: M J Ricciardi; E Wu; C J Davidson; K M Choi; F J Klocke; R O Bonow; R M Judd; R J Kim Journal: Circulation Date: 2001-06-12 Impact factor: 29.690
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Cassianne Robinson-Cohen; Michael Shlipak; Mark Sarnak; Ronit Katz; Carmen Peralta; Bessie Young; Andrew N Hoofnagle; Moyses Szklo; Joachim H Ix; Bruce M Psaty; Ian H de Boer; Bryan Kestenbaum; Nisha Bansal Journal: J Clin Endocrinol Metab Date: 2020-04-01 Impact factor: 5.958
Authors: Christopher L Schlett; Quynh A Truong; Waleed Ahmed; Ron Blankstein; Maros Ferencik; Shanmugam Uthamalingam; Fabian Bamberg; Wolfgang Koenig; James L Januzzi; Udo Hoffmann Journal: Int J Cardiovasc Imaging Date: 2013-01-01 Impact factor: 2.357
Authors: Kai Lin; Leng Meng; Jeremy D Collins; Varun Chowdhary; Michael Markl; James C Carr Journal: Int J Cardiovasc Imaging Date: 2016-10-25 Impact factor: 2.357
Authors: Ravi V Shah; Venkatesh L Murthy; Siddique A Abbasi; John Eng; Colin Wu; Pamela Ouyang; Raymond Y Kwong; Allison Goldfine; David A Bluemke; Joao Lima; Michael Jerosch-Herold Journal: Eur J Prev Cardiol Date: 2014-07-09 Impact factor: 7.804
Authors: Ravi V Shah; Siddique A Abbasi; Bobak Heydari; Carsten Rickers; David R Jacobs; Lu Wang; Raymond Y Kwong; David A Bluemke; Joao A C Lima; Michael Jerosch-Herold Journal: J Am Coll Cardiol Date: 2013-04-23 Impact factor: 24.094
Authors: Eui-Young Choi; Boaz D Rosen; Veronica R S Fernandes; Raymond T Yan; Kihei Yoneyama; Sirisha Donekal; Anders Opdahl; Andre L C Almeida; Colin O Wu; Antoinette S Gomes; David A Bluemke; Joao A C Lima Journal: Eur Heart J Date: 2013-05-03 Impact factor: 29.983
Authors: Kai Lin; Jeremy D Collins; Varun Chowdhary; Michael Markl; James C Carr Journal: Int J Cardiovasc Imaging Date: 2016-04-13 Impact factor: 2.357
Authors: Marwah Abdalla; Elvis A Akwo; David A Bluemke; João A C Lima; Daichi Shimbo; Mathew S Maurer; Alain G Bertoni Journal: Int J Cardiol Date: 2019-07-11 Impact factor: 4.164
Authors: Amer I Aladin; Elsayed Z Soliman; Dalane W Kitzman; Zeina Dardari; Shereen H Rasool; Joseph Yeboah; Matthew J Budoff; Bruce M Psaty; Pamela Ouyang; Joseph F Polak; Roger S Blumenthal; John W McEvoy; Sanjay K Gandhi; David M Herrington Journal: Am J Cardiol Date: 2021-03-03 Impact factor: 3.133